{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:06:19Z","timestamp":1769511979543,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005146.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000}}],"reference-count":121,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005146.pub3","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T04:51:16Z","timestamp":1480049476000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Haloperidol plus promethazine for psychosis-induced aggression"],"prefix":"10.1002","volume":"2016","author":[{"given":"Gisele","family":"Huf","sequence":"first","affiliation":[{"name":"Oswaldo Cruz Foundation; National Institute of Quality Control in Health; Av. Brasil 4365 Manguinhos Rio de Janeiro Brazil 21040-9000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Alexander","sequence":"additional","affiliation":[{"name":"Mental Health Centre, Christian Medical Centre; Department of Psychiatry; Unit 2 Bagayam Vellore Tamil Nadu India 632002"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinky","family":"Gandhi","sequence":"additional","affiliation":[{"name":"48 Waddington Drive West Bridgford Nottingham UK NG2 7GX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Allen","sequence":"additional","affiliation":[{"name":"University of Colorado Depression Centre; Department of Psychiatry; 13199 East Montview Boulevard Aurora Colorado USA 80045"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-44462011000100008","article-title":"Rapid tranquilization for agitated patients in emergency psychiatric rooms: A randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone","volume":"33","author":"Baldacara","year":"2011","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JCP.0b013e3182900fd6","article-title":"Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, rated-blind trial of 4 intramuscular interventions","volume":"33","author":"Mantovani","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0003|cit3","first-page":"220","article-title":"Physical restraints for agitated patients in psychiatric emergency hospitals in Rio de Janeiro, Brazil: a predictive model","volume":"31","author":"Coutinho","year":"2005","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0009|cit4","unstructured":"Huf G Rapid safe tranquillisation for acutely disturbed people attending public psychiatric emergency clinics in Rio de Janeiro http:\/\/www.isrctn.com\/ISRCTN44153243"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005146.pub3-BIB0004|cit5","first-page":"187","article-title":"TREC I. Background","volume":"53","author":"Huf","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005146.pub3-BIB0005|cit6","first-page":"187","article-title":"TREC III. The protocol and progress of TREC","volume":"53","author":"Huf","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-244X-2-11","article-title":"TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms","volume":"2","author":"Huf","year":"2002","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0007|cit8","unstructured":"Huf G Coutinho ESF Adams CE The pharmacological management of agitated patients in emergency psychiatric hospitals in Rio de Janeiro, Brazil: the results of two pragmatic randomized clinical trials 5th European Congress on Violence in Clinical Psychiatry; 25-27 October 2007; Amsterdam, the Netherlands 2007"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0008|cit9","first-page":"236","article-title":"TREC II. Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro, Brazil","volume":"53","author":"Huf","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.genhosppsych.2007.12.005","article-title":"Factors associated with the use of physical restraints for agitated patients in psychiatric emergency rooms","volume":"30","author":"Migon","year":"2008","journal-title":"General Hospital Psychiatry"},{"issue":"7417","key":"10.1002\/14651858.CD005146.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.327.7417.708","article-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine","volume":"327","author":"TREC Collaborative Group","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ebmh.11.3.86","article-title":"Intramuscular haloperidol plus promethazine is more effective and safer than haloperidol alone for rapid tranquillisation of agitated mentally ill patients","volume":"11","author":"Barbui","year":"2008","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0015|cit13","unstructured":"Huf G Haloperidol plus promethazine versus haloperidol for psychosis induced aggression Unpublished protocol 2004"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0013|cit14","unstructured":"Huf G Coutinho ESF Adams CE The pharmacological management of agitated patients in emergency psychiatric hospitals in Rio de Janeiro, Brazil: the results of two pragmatic randomized clinical trials 5th European Congress on Violence in Clinical Psychiatry; 25-27 October 2007; Amsterdam, the Netherlands 2007"},{"issue":"7625","key":"10.1002\/14651858.CD005146.pub3-BIB0014|cit15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bmj.39339.448819.AE","article-title":"Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haliperidol versus intramuscular haloperidol plus promethazine","volume":"335","author":"Huf","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0016|cit16","unstructured":"ISRCTN83261243 TREC2 - Rapid tranquillisation for agitated patients in emergency psychiatric rooms in Rio de Janeiro. A randomised trial of intramuscular Haloperidol versus intramuscular Haloperidol + Promethazine http:\/\/www.isrctn.com\/ISRCTN83261243"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0019|cit17","volume-title":"Lorazepam Versus a Combination of Haloperidol and Promethazine in the Acute Management of Agitation and Aggression - a Randomized Controlled Trial [MD Thesis]","author":"Alexander","year":"2003"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005146.pub3-BIB0017|cit18","first-page":"236","article-title":"TREC-India. A second arm of TREC","volume":"53","author":"Alexander","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquilisation of violent or agitated patients in a psychiatric emergancy setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0020|cit20","unstructured":"Tharyan P A randomised controlled trial of intra-muscular lorazepam versus intra-muscular haloperidol+promethazine in the management of psychotic agitations and aggression http:\/\/www.isrctn.com\/ISRCTN29863938"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ebmh.11.3.86","article-title":"Intramuscular haloperidol plus promethazine is more effective and safer than haloperidol alone for rapid tranquillisation of agitated mentally ill patients","volume":"11","author":"Barbui","year":"2008","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0022|cit22","unstructured":"NCT00455234 Rapid tranquilization of violent or agitated people in psychiatric emergency settings - a pragmatic randomized controlled trial of intramuscular olanzapine vs intramuscular haloperidol + promethazine https:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00455234"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0023|cit23","unstructured":"Nirmal SR Rapid tranquillization of acutely agitated patients: intramuscular olanzapine vs haloperidol + promethazine - pragmatic randomized control trial 5th European Congress on Violence in Clinical Psychiatry; 25-27 October 2007; Amsterdam, the Netherlands 2007"},{"issue":"7625","key":"10.1002\/14651858.CD005146.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.39341.608519.BE","article-title":"Rapid tranquillisation in psychiatirc emergency settings in India: a pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine","volume":"335","author":"Raveendran","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0025|cit25","unstructured":"Tharyan P Alexander J Haloperidol plus promethazine versus IM olanzapine Data on file 2004"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0026|cit26","unstructured":"Tharyan P Alexander J Haloperidol plus promethazine versus IM olanzapine Unpublished protocol 2004"},{"issue":"2","key":"10.1002\/14651858.CD005146.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2003-39043","article-title":"Antipsychotic efficacy of the antidepressant trimipramine: A randomized, double-blind comparison with the phenothiazine perazine","volume":"36","author":"Bender","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archpsyc.1969.01740210028004","article-title":"Effects of selected phenothiazines on REM sleep in schizophrenics","volume":"21","author":"Brannen","year":"1969","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0022-510X(75)90165-3","article-title":"Tardive dyskinesia treated with pimozide","volume":"24","author":"Claveria","year":"1975","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00429387","article-title":"Effects of various drugs on flicker fusion frequency. II. Phenothiazine derivatives (with reference to the dependence of the results on the chronological course of experiments","volume":"27","author":"Graupner","year":"1972","journal-title":"Psychopharmacologia"},{"issue":"07","key":"10.1002\/14651858.CD005146.pub3-BIB0031|cit31","first-page":"787","article-title":"Risperidone oral solution with lorazepam treatment of schizophrenia excited state","volume":"19","author":"\u4faf\u6625\u5170","year":"2011","journal-title":"China Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0032|cit32","first-page":"113","article-title":"Comparison of three kinds of antiparkinsonian agents (piroheptine=fk-1190, trihexyphenidyl and promethazine) in drug-induced extrapyramidal symptoms using double-blind technique","volume":"1","author":"Itoh","year":"1972","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/h0045486","article-title":"A comparison of the effects of phenobarbital, promethazine, chlorpromazine, and placebo upon mental hospital patients","volume":"23","author":"Levin","year":"1959","journal-title":"Journal of Consulting Psychology"},{"issue":"10","key":"10.1002\/14651858.CD005146.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v63n1006","article-title":"Risperidone, 2 mg\/day vs. 4 mg\/day, in first-episode, acutely psychotic patients: Treatment efficacy and effects on fine motor functioning","volume":"63","author":"Merlo","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0035|cit35","first-page":"223","article-title":"Comparison of clinical efficacy of methixene, trihexyphenidyl and promethazine in drug-induced parkinsonism using double blind cross-over technique","volume":"6","author":"Otsuka","year":"1978","journal-title":"Clinical Evaluation"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2007-1014590","article-title":"A pilot study of the role of prophylactic antiparkinson treatment during neuroleptic therapy","volume":"22","author":"Perenyi","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0037|cit37","first-page":"S21","article-title":"A comparative study of injection haloperidol and promethazine vs. injection lorazepam in controlling acute psychotic agitation","volume":"52","author":"Srinath","year":"2010","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.120.12.1189","article-title":"Interchangeability of antiparkinsonian medication","volume":"120","author":"St. Jean","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD005146.pub3-BIB0039|cit39","first-page":"526","article-title":"Clinical studies with propericiazine (RP. 8909)","volume":"28","author":"St. Jean","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0040|cit40","first-page":"1311","article-title":"Comparison of clinical efficacy of mazaticol hydrochloride, trihexyphenidyl and promethazine for drug-induced parkinsonism: comparison by the double-blind, cross-over method","volume":"2","author":"Yagi","year":"1973","journal-title":"Seishin Igaku"},{"issue":"6","key":"10.1002\/14651858.CD005146.pub3-BIB0041|cit41","first-page":"365","article-title":"Promethazine treatment of tardive dyskinesia: a double blind placebo controlled study","volume":"13","author":"Yang","year":"1999","journal-title":"Chinese Mental Health Journal"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0042|cit42","unstructured":"Mythri SV Tharyan P Sunder S Kattula D Kirubakaran R Adams CE CTRI-2014-07-004712: Rapid tranquillization of violent or agitated patients in a psychiatric emergency setting: Pragmatic, randomized, allocation concealed, participant and assessor blinded trial of intramuscular zuclopenthixol acetate versus intramuscular haloperidol plus promethazine http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=CTRI\/2014\/07\/004712"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0043|cit43","unstructured":"Mythri SV Tharyan P Sunder S Kattula D Kirubakaran R Adams CE Rapid tranquillization of violent or agitated patients in a psychiatric emergency setting: Pragmatic, randomized, allocation concealed, participant and assessor blinded trial of intramuscular zuclopenthixol acetate versus intramuscular haloperidol plus promethazine - a comparative study of the effects of an intramuscular injection of zuclopenthixol acetate versus an intramuscular injection of a combination of haloperidol plus promethazine in people with violence or agitation presenting to a psychiatric hospital as an emergency Study Protocol 2013"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003082.pub3","article-title":"Haloperidol versus placebo for schizophrenia","author":"Adams","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub3","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007445.pub2","article-title":"Chlorpromazine for psychosis-induced aggression or agitation","author":"Ahmed","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009412","article-title":"Risperidone for psychosis induced aggression or agitation","author":"Ahmed","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0048|cit48","volume-title":"Lorazepam Versus a Combination of Haloperidol and Promethazine in the Acute Management of Agitation and Aggression - a Randomized Controlled Trial [Thesis submitted for the Degree of MD Psychological Medicine]","author":"Alexander","year":"2003"},{"issue":"7066","key":"10.1002\/14651858.CD005146.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0050|cit50","first-page":"459","article-title":"Haloperidol: fifteen years of clinical experience","volume":"33","author":"Ayd","year":"1972","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0051|cit51","first-page":"807","article-title":"Haloperidol: twenty years' clinical experience","volume":"39","author":"Ayd","year":"1978","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005146.pub3-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003729.pub2","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002304.pub2","article-title":"Clotiapine for acute psychotic illnesses","author":"Berk","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1176\/ps.50.12.1553","article-title":"Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms","volume":"50","author":"Binder","year":"1999","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0057|cit57","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"5","key":"10.1002\/14651858.CD005146.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003441.pub2","article-title":"'As required' medication regimens for seriously mentally ill people in hospital","author":"Chakrabarti","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/pb.18.3.138","article-title":"Drug management of disturbed behaviour by psychiatrists","volume":"18","author":"Cunnane","year":"1994","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0061|cit61","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium. 25-28 Oct 2000 Cape Town, South Africa Cape Town The Cochrane Collaboration"},{"issue":"6","key":"10.1002\/14651858.CD005146.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD005146.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009546.pub2","article-title":"Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia","author":"Essali","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005146.pub3-BIB0067|cit67","first-page":"3","article-title":"Treatment of schizophrenia 1999. The expert consensus guideline series","volume":"60","author":"Expert Consensus Guideline Group","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD005146.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Gibson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003079.pub2","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","author":"Gillies","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003079.pub3","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","author":"Gillies","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0073|cit73","first-page":"76","article-title":"Clinical Global Impressions","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0075|cit75","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume-title":"The Cochrane Library","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0076|cit76","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-2-4","article-title":"Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study","volume":"2","author":"Huf","year":"2002","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-244X-2-11","article-title":"TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms","volume":"2","author":"Huf","year":"2002","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1745-6215-12-180","article-title":"TREC-SAVE: a randomised trial comparing mechanical restraints with use of seclusion for aggressive or violent seriously mentally ill people: study protocol for a randomised controlled trial","volume":"12","author":"Huf","year":"2011","journal-title":"Trials"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1017\/S0033291712000372","article-title":"Physical restraints versus seclusion room for management of people with acute aggression or agitation due to psychotic illness (TREC-SAVE): a randomized trial","volume":"42","author":"Huf","year":"2012","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0081|cit81","first-page":"1","article-title":"Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study","volume":"Monograph Suppl","author":"Jablensky","year":"1992","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0083|cit83","volume-title":"Kaplan and Sadock's Synopsis of Psychiatry","author":"Kaplan","year":"1994"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0084|cit84","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"5","key":"10.1002\/14651858.CD005146.pub3-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009830","article-title":"Haloperidol for long term aggression in psychosis","author":"Khushu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010226.pub2","article-title":"Trifluoperazine versus placebo for schizophrenia","author":"Koch","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD005146.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007474.pub2","article-title":"Risperidone dose for schizophrenia","author":"Li","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.180.6.485","article-title":"Rapid tranquillisation: time for a reappraisal of options for parenteral therapy","volume":"180","author":"McAllister-Williams","year":"2002","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-9-18","article-title":"Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room","volume":"9","author":"Montoya","year":"2011","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0094|cit94","first-page":"1630","article-title":"Patients in a state of agitation at the admission service of a Rouen hospital emergency department","volume":"28","author":"Moritz","year":"1999","journal-title":"Presse Medicale"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001949.pub3","article-title":"Pimozide for schizophrenia or related psychoses","author":"Mothi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002084.pub2","article-title":"Containment strategies for people with serious mental illness","author":"Muralidharan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0097|cit97","unstructured":"National Institute for Clinical Evidence (NICE) Disturbed (violent) behaviour: the short-term management of disturbed (violent) behaviour in in-patient psychiatric settings and emergency departments. Clinical Guideline 25 www.nice.org.uk\/pdf\/cg025niceguideline.pdf [accessed 2005]"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0098|cit98","unstructured":"National Collaborating Centre for Mental Health (UK) Violence and aggression: short-term management in mental health, health and community settings: updated edition National Institute for Health and Clinical Excellence: Guidance 2015"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1192\/bjp.160.6.831","article-title":"Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital","volume":"160","author":"Pilowsky","year":"1992","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009377.pub2","article-title":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)","author":"Powney","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.2.5920.656","article-title":"Controlled sedation with alphaxalone-alphadolone","volume":"2","author":"Ramsay","year":"1974","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD005146.pub3-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009922","article-title":"De-escalation techniques for psychosis-induced aggression or agitation","author":"Rao","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002830.pub2","article-title":"Droperidol for acute psychosis","author":"Rathbone","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0105|cit105","volume-title":"Management of Imminent Violence: Clinical Practice Guidelines to Support Mental Health services","author":"The Royal College of Psychiatrists","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD005146.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001163","article-title":"Seclusion and restraint for people with serious mental illnesses","author":"Sailas","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212 (Suppl 44)","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD005146.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0109|cit109","unstructured":"Toal F Roberts K Clozapine for people with schizophrenia and recurrent physical aggression Cochrane Database of Systematic Reviews 2012"},{"issue":"2","key":"10.1002\/14651858.CD005146.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.31887\/DCNS.2011.13.2\/gtosh","article-title":"Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials","volume":"13","author":"Tosh","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD005146.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"11","key":"10.1002\/14651858.CD005146.pub3-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010190","article-title":"Loxapine inhaler for psychosis-induced aggression","author":"Vangala","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0113|cit113","unstructured":"WHO Expert Committee World Health Organization\/EDM\/PAR\/Procedures for Updating the WHO Model List of Essential Drugs www.who.int\/medicines\/organization\/par\/edl\/infedlmain.shtml"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009801","article-title":"Quetiapine for psychosis-induced aggression or agitation","author":"Wilkie","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005146.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD005146.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The Overt Aggression Scale for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1176\/jnp.9.4.541","article-title":"The Overt Agitation Severity Scale for the objective rating of agitation","volume":"9","author":"Yudofsky","year":"1997","journal-title":"Journal of Neuropsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005146.pub3-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146","article-title":"Haloperidol plus promethazine for psychosis induced aggression","author":"Huf","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005146.pub3-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146","article-title":"Haloperidol plus promethazine for psychosis induced aggression","author":"Huf","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146.pub2","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","author":"Huf","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005146.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/S1516-44462009000300014","article-title":"Haloperidol plus promethazine for agitated patients - a systematic review","volume":"31","author":"Huf","year":"2009","journal-title":"Revista Brasileira de Psiquiatria"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005146.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:39:22Z","timestamp":1636576762000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005146.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":121,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005146.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}